Business Development leadership team

The partners who build teams

Our Business Development team is structured by therapeutic area to ensure we have the right expertise to identify, evaluate and transact on the right opportunities. Our Business Development leaders bring deep science, development and business expertise and work closely with R&D and commercial leaders to source external innovation that will augment our internal pipeline. 
 
Giovanni Caforio, M.D., Chairman and CEO, Bristol-Myers Squibb
   

"We are open to a wide range of partnership opportunities focused on transformational science and we are committed to being a leading biopharma partner."

 

Elizabeth Mily, Executive Vice President Strategy and Business Development

Cardiovascular, Fibrosis, Immunology and Neuroscience

image1
Jeff Staiger
Vice President, Cardiovascular, Fibrosis, Immunology, Neuroscience Business Development
Summit, NJ
Anna Rivkin, Ph.D.
Anna Rivkin, Ph.D.
Executive Director, Business Development, Cardiovascular, Fibrosis, Immunology, Neuroscience, Japan Search & Evaluation
Lawrenceville, NJ
Yoshi Maeda
Yoshitake Maeda
Director, Search & Evaluation, Japan & Asia, Business Development
Toyko, Japan
Dan Ring
Dan Ring
Executive Director, Business Development, Cardiovascular, Fibrosis, Immunology, Neuroscience Transactions
Lawrenceville, NJ

Corporate Development

image1
Brian Heaphy
Vice President, Corporate Development
Lawrenceville, NJ
Robert Merriman
Robert Merriman
Executive Director, Corporate Development Transactions
Lawrenceville, NJ
Daniel O'Connell
Daniel O'Connell
Executive Director, Equity and Venture Capital
Lawrenceville, NJ
Sunil Patel
Sunil Patel
Senior Director, Divestitures
Lawrenceville, NJ

Hematology, Cell Therapy & China

Jie D'Elia
Jie D'Elia
Vice President, Business Development, Hematology, Cell Therapy and China
Lawrenceville, NJ
Stephen O'Keefe
Stephen O'Keefe
Senior Director, Business Development, Hematology Search & Evaluation
Summit, NJ
Daniel O'Connell
Ken LaMontagne, Ph.D, MBA
Senior Director, Business Development, Cell Therapy Search & Evaluation
Lawrenceville, NJ
Jennifer Schwartz
Jennifer Schwartz
Executive Director, Business Development, Hematology & Cell Therapy Transactions
Lawrenceville, NJ
Fang Zhang
Fang Zhang
Executive Director, China Business Development

Innovative Technologies 

Konstantina Katcheves
Konstantina Katcheves
Vice President, Innovative Technologies Business Development
Lawrenceville, NJ
Michael Cucolo
Michael Cucolo
Executive Director, Business Development, Research Enabling Transactions
Lawrenceville, NJ
Jay Foust
Jay Foust
Executive Director, Business Development, Translational Medicine
Lawrenceville, NJ
Michael McInerney
Michael McInerney
Senior Director, Business Development, Digital Health
Lawrenceville, NJ

Oncology

Janusz Kostanski
Janusz Kostanski, Ph.D.
Vice President, Oncology Business Development
Lawrenceville, NJ
 Martin Cook
Martin Crook
Executive Director, Business Development, Oncology Search & Evaluation
Lawrenceville, NJ
Michael Cucolo
Brian Cook
Executive Director, Business Development, Oncology Transactions
Lawrenceville, NJ

Transactional Excellence

Janette Dean
Janette Dean
Vice President, Transactional Excellence
Chester, UK

Interested in working with us? 

Begin a discussion >

our area of interest